Ten-Year Incidence and Progression of Age-Related Maculopathy. The Blue Mountains Eye Study

Ophthalmology

Volumn 114, Issue 1, 2007, Pages 92-98

  Wang, Jie Jin ^a   Rochtchina, Elena ^a   Lee, Anne J ^a   Chia, Ee Munn ^a   Smith, Wayne ^b   Cumming, Robert G ^c,d   Mitchell, Paul ^a  

^a WESTMEAD HOSPITAL   (Australia)

^b UNIVERSITY OF NEWCASTLE   (Australia)

^c UNIVERSITY OF SYDNEY   (Australia)

^d UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; ATROPHY; AUSTRALIA; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; DRUSEN; EYE PHOTOGRAPHY; FEMALE; FOLLOW UP; HIGH RISK POPULATION; HUMAN; INCIDENCE; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PREDICTOR VARIABLE; PRIORITY JOURNAL; RETINA MACULA AGE RELATED DEGENERATION; RETINA NEOVASCULARIZATION; RETINA PIGMENT DEGENERATION; RISK ASSESSMENT; RISK FACTOR; SCORING SYSTEM; STANDARDIZATION; SURVIVOR;

AGED; AGED, 80 AND OVER; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; MACULAR DEGENERATION; MALE; MIDDLE AGED; NEW SOUTH WALES; PHOTOGRAPHY; RISK FACTORS;

EID: 33845754932     PISSN: 01616420     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ophtha.2006.07.017     Document Type: Article

References (49)

1. Rahmani B., Tielsch J.M., Katz J., et al. The cause-specific prevalence of visual impairment in an urban population: the Baltimore Eye Survey. Ophthalmology 103 (1996) 1721-1726
2. Klaver C.C., Wolfs R.C., Vingerling J.R., et al. Age-specific prevalence and causes of blindness and visual impairment in an older population: the Rotterdam Study. Arch Ophthalmol 116 (1998) 653-658
3. Wang J.J., Foran S., and Mitchell P. Age-specific prevalence and causes of bilateral and unilateral visual impairment in older Australians: the Blue Mountains Eye Study. Clin Experiment Ophthalmol 28 (2000) 268-273
4. Rodriguez J., Sanchez R., Munoz B., et al. Causes of blindness and visual impairment in a population-based sample of U.S. Hispanics. Ophthalmology 109 (2002) 737-743
5. Evans J.R., Fletcher A.E., and Wormald R.P. Age-related macular degeneration causing visual impairment in people 75 years or older in Britain: an add-on study to the Medical Research Council Trial of Assessment and Management of Older People in the Community. Ophthalmology 111 (2004) 513-517
6. Ambati J., Ambati B.K., Yoo S.H., et al. Age-related macular degeneration: etiology, pathogenesis, and therapeutic strategies. Surv Ophthalmol 48 (2003) 257-293
7. Fine S.L. Age-related macular degeneration 1969-2004: a 35-year personal perspective. Am J Ophthalmol 139 (2005) 405-420
8. Friedman D.S., Katz J., Bressler N.M., et al. Racial differences in the prevalence of age-related macular degeneration: the Baltimore Eye Survey. Ophthalmology 106 (1999) 1049-1055
9. Klein R., Klein B.E., and Linton K.L. Prevalence of age-related maculopathy: the Beaver Dam Eye Study. Ophthalmology 99 (1992) 933-943
10. Schachat A.P., Hyman L., Leske M.C., et al. Features of age-related macular degeneration in a black population: the Barbados Eye Study Group. Arch Ophthalmol 113 (1995) 728-735
11. Vingerling J.R., Dielemans I., Hofman A., et al. The prevalence of age-related maculopathy in the Rotterdam Study. Ophthalmology 102 (1995) 205-210
12. Mitchell P., Smith W., Attebo K., and Wang J.J. Prevalence of age-related maculopathy in Australia: the Blue Mountains Eye Study. Ophthalmology 102 (1995) 1450-1460
13. Klein R., Clegg L., Cooper L.S., et al. Prevalence of age-related maculopathy in the Atherosclerosis Risk in Communities Study. Arch Ophthalmol 117 (1999) 1203-1210
14. VanNewkirk M.R., Nanjan M.B., Wang J.J., et al. The prevalence of age-related maculopathy: the Visual Impairment Project. Ophthalmology 107 (2000) 1593-1600
15. Oshima Y., Ishibashi T., Murata T., et al. Prevalence of age related maculopathy in a representative Japanese population: the Hisayama Study. Br J Ophthalmol 85 (2001) 1153-1157
16. Klein R., Klein B.E., Marino E.K., et al. Early age-related maculopathy in the Cardiovascular Health Study. Ophthalmology 110 (2003) 25-33
17. Jonasson F., Arnarsson A., Sasaki H., et al. The prevalence of age-related maculopathy in Iceland: Reykjavik Eye Study. Arch Ophthalmol 121 (2003) 379-385
18. Varma R., Fraser-Bell S., Tan S., et al. Prevalence of age-related macular degeneration in Latinos. The Los Angeles Latino Eye Study. Ophthalmology 111 (2004) 1288-1297
19. Eye Diseases Prevalence Research Group. Prevalence of age-related macular degeneration in the United States. Arch Ophthalmol 122 (2004) 564-572
20. Owen C.G., Fletcher A.E., Donoghue M., and Rudnicka A.R. How big is the burden of visual loss caused by age related macular degeneration in the United Kingdom?. Br J Ophthalmol 87 (2003) 312-317
21. Klein R., Klein B.E., Jensen S.C., and Meuer S.M. The five-year incidence and progression of age-related maculopathy: the Beaver Dam Eye Study. Ophthalmology 104 (1997) 7-21
22. Klaver C.C., Assink J.J., van Leeuwen R., et al. Incidence and progression rates of age-related maculopathy: the Rotterdam Study. Invest Ophthalmol Vis Sci 42 (2001) 2237-2241
23. Mitchell P., Wang J.J., Foran S., and Smith W. Five-year incidence of age-related maculopathy lesions: the Blue Mountains Eye Study. Ophthalmology 109 (2002) 1092-1097
24. van Leeuwen R., Klaver C.C., Vingerling J.R., et al. The risk and natural course of age-related maculopathy: follow-up at 6 1/2 years in the Rotterdam Study. Arch Ophthalmol 121 (2003) 519-526
25. Mukesh B.N., Dimitrov P.N., Leikin S., et al. Five-year incidence of age-related maculopathy. The Visual Impairment Project. Ophthalmology 111 (2004) 1176-1182
26. Jonasson F., Arnarsson A., Peto T., et al. 5-year incidence of age-related maculopathy in the Reykjavik Eye Study. Ophthalmology 112 (2005) 132-138
27. Miyazaki M., Kiyohara Y., Yoshida A., et al. The 5-year incidence and risk factors for age-related maculopathy in a general Japanese population: the Hisayama Study. Invest Ophthalmol Vis Sci 46 (2005) 1907-1910
28. Smith W., Assink J., Klein R., et al. Risk factors for age-related macular degeneration: pooled findings from three continents. Ophthalmology 108 (2001) 697-704
29. Tomany S.C., Wang J.J., van Leeuwen R., et al. Risk factors for incident age-related macular degeneration. Pooled findings from 3 continents. Ophthalmology 111 (2004) 1280-1287
30. Klein R., Davis M., Magli Y., et al. The Wisconsin Age-Related Maculopathy Grading System. Ophthalmology 98 (1991) 1128-1134
31. Bird A.C., Bressler N.M., Bressler S.B., et al. An international classification and grading system for age-related maculopathy and age-related macular degeneration. Surv Ophthalmol 39 (1995) 367-374
32. Age-Related Eye Disease Study Research Group. A simplified severity scale for age-related macular degeneration: AREDS report no. 18. Arch Ophthalmol 123 (2005) 1570-1574
33. Klein R., Klein B.E., Tomany S.C., et al. Ten-year incidence and progression of age-related maculopathy: the Beaver Dam Eye Study. Ophthalmology 109 (2002) 1767-1779
34. Hosmer Jr. D.W., and Lemeshow S. Applied Logistic Regression (1989), Wiley, New York 238-245
35. Katz J., Zeger S., and Liang K.Y. Appropriate statistical methods to account for similarities in binary outcomes between fellow eyes. Invest Ophthalmol Vis Sci 35 (1994) 2461-2465
36. Glynn R.J., and Rosner B. Accounting for the correlation between fellow eyes in regression analysis. Arch Ophthalmol 110 (1992) 381-387
37. Buch H., Vinding T., la Cour M., et al. Risk factors for age-related maculopathy in a 14-year follow-up study: the Copenhagen City Eye Study. Acta Ophthalmol Scand 83 (2005) 409-418
38. Gregor Z., Bird A.C., and Chisholm I.H. Senile disciform macular degeneration in the second eye. Br J Ophthalmol 61 (1977) 141-147
39. Strahlman E.R., Fine S.L., and Hillis A. The second eye of patients with senile macular degeneration. Arch Ophthalmol 101 (1983) 1191-1193
40. Roy M., and Kaiser-Kupfer M. Second eye involvement in age-related macular degeneration: a four-year prospective study. Eye 4 (1990) 813-818
41. Macular Photocoagulation Study Group. Five-year follow-up of fellow eyes of patients with age-related macular degeneration and unilateral extrafoveal choroidal neovascularization. Arch Ophthalmol 111 (1993) 1189-1199
42. Chang B., Yannuzzi L.A., Ladas I.D., et al. Choroidal neovascularization in second eyes of patients with unilateral exudative age-related macular degeneration. Ophthalmology 102 (1995) 1380-1386
43. Sandberg M.A., Weiner A., Miller S., and Gaudio A.R. High-risk characteristics of fellow eyes of patients with unilateral neovascular age-related macular degeneration. Ophthalmology 105 (1998) 441-447
44. Pieramici D.J., and Bressler S.B. Age-related macular degeneration and risk factors for the development of choroidal neovascularization in the fellow eye. Curr Opin Ophthalmol 9 (1998) 38-46
45. Uyama M., Takahashi K., Ida N., et al. The second eye of Japanese patients with unilateral exudative age related macular degeneration. Br J Ophthalmol 84 (2000) 1018-1023
46. Wang J.J., Foran S., Smith W., and Mitchell P. Risk of age-related macular degeneration in eyes with macular drusen or hyperpigmentation: the Blue Mountains Eye Study cohort. Arch Ophthalmol 121 (2003) 658-663
47. Age-Related Eye Disease Study Research Group. The Age-Related Eye Disease Study severity scale for age-related macular degeneration: AREDS report no. 17. Arch Ophthalmol 123 (2005) 1484-1498
48. Mitchell P., and Foran S. Age-Related Eye Disease Study Severity Scale and Simplified Severity Scale for Age-Related Macular Degeneration. Arch Ophthalmol 123 (2005) 1598-1599
49. Kelly S.P., Edwards R., Elton P., and Mitchell P. Age related macular degeneration: smoking entails major risk of blindness [letter]. BMJ 326 (2003) 1458-1459